Anemia Clinical Trial
Official title:
Impact of the Evaluation of the Enhanced Homestead Food Production Program in Sengerema, and Ukerewe in the Lake Zone,Tanzania
The purpose of this study is to assess if the Enhanced Homestead Food Production Plus (EHFP+) Program implemented by HKI in Mwanza, Tanzania, enhances uptake of Micronutrient Powder (MNP) supplementation in children, helps maintaining reduced anemia levels among children after a blanket provision of MNP, and has an impact on child growth, infant and young child feeding (IYCF) practices, maternal knowledge related to health, nutrition, WASH and malaria prevention, food security and women's empowerment.
Since 1988, Helen Keller International's (HKI) flagship Homestead Food Production (HFP)
program in Asia has helped communities establish technically-improved local food production
systems by creating gardens yielding micronutrient-rich fruits and vegetables over expanded
growing seasons, complemented by the improved rearing of poultry and livestock.
In 2010, HKI introduced an enhanced-HFP (E-HFP) model in Burkina Faso and included a
strengthened nutrition education component; the Essential Nutrition Actions (ENA) framework.
This E-HFP program was evaluated by IFPRI and yielded some encouraging results. With regards
to nutritional outcomes, however, the primary finding was that, while the E-HFP program
improved hemoglobin concentration—an indicator of iron status—the evaluation failed to note
a significant impact of the program on improving children's growth. The primary explanation
for the absence of a measurable improvement in children's growth was the lack of
complementary health interventions that aim to specifically reduce children's disease
burden, which, along with the lack of adequate food and care, is an underlying cause of
undernutriton (UNICEF 1990).
Building on lessons learned from the Burkina Faso E-HFP program and a 2011 Tanzania HFP
program, a new model, the Enhanced Homestead Food Production Plus (E-HFP+), was developed
for Tanzania to improve the nutritional status of infants and young children. The new model
strengthens the Behavior Change Communication (BCC) on malaria prevention, WASH, and gender
components and enhances links with the health sector. The model will also test two new
concepts:
1. to assess if the E-HFP+ program has the potential to maintain adequate levels of
hemoglobin concentrations by increasing iron-rich food consumption and malaria
prevention good practices.
2. to assess the effectiveness on anemia of using an existing agriculture-based platform
to promote uptake and utilization of MNP.
The model involves both a set of production and nutrition interventions targeted to mothers
and the provision of a curative treatment for moderate to severe anemia (Micronutrient
Powder).
The main objective of the impact evaluation of the E-HFP+ program is therefore to assess
whether the program:
- Maintains reduced anemia levels among pre-school aged children after a blanket
provision of Micronutrient Powder (MNP)
- Improves child growth (measured by HAZ and WHZ)
- Improves infant and young child feeding (IYCF) practices and maternal knowledge on
health and nutrition
- Is an appropriate delivery platform to enhance uptake and utilization of MNP
supplementation in children
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 |